Caitriona M. O'driscoll

Cork, M, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Navigating patient access pathways for non-viral RNA-based therapeutics: a comparative review of health technology assessment and reimbursement pathways across six countries.

Navigating patient access pathways for non-viral RNA-based therapeutics: a comparative review of health technology assessment and reimbursement pathways across six countries.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: May 01, 2026

MAPPING current decision-making pathways and reimbursement processes for high-risk medical devices in EU/EEA member states and the UK: a scoping review.

MAPPING current decision-making pathways and reimbursement processes for high-risk medical devices in EU/EEA member states and the UK: a scoping review.

Journal: International journal of technology assessment in health care

Published: October 20, 2025

The Early Experiences of Health Technology Assessment Bodies in the Implementation of the European Union Health Technology Assessment Regulation for High-Risk Medical Devices: A Qualitative Study.

The Early Experiences of Health Technology Assessment Bodies in the Implementation of the European Union Health Technology Assessment Regulation for High-Risk Medical Devices: A Qualitative Study.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: August 17, 2025

Advancing 3D scaffold models for metastatic prostate cancer in bone: Materials, manufacture, and future perspectives.

Advancing 3D scaffold models for metastatic prostate cancer in bone: Materials, manufacture, and future perspectives.

Journal: Biomaterials and biosystems

Published: July 04, 2025

M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy.

M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy.

Journal: Molecular pharmaceutics

Published: October 24, 2023

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin.

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin.

Journal: Pharmaceutics

Published: December 21, 2022

Nano-Hydroxyapatite/PLGA Mixed Scaffolds as a Tool for Drug Development and to Study Metastatic Prostate Cancer in the Bone.

Nano-Hydroxyapatite/PLGA Mixed Scaffolds as a Tool for Drug Development and to Study Metastatic Prostate Cancer in the Bone.

Journal: Pharmaceutics

Published: December 08, 2022

Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.

Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: November 23, 2022

Strategies to Mitigate and Treat Orthopaedic Device-Associated Infections.

Strategies to Mitigate and Treat Orthopaedic Device-Associated Infections.

Journal: Antibiotics (Basel, Switzerland)

Published: November 11, 2022

The gut microbiota is important for the maintenance of blood-cerebrospinal fluid barrier integrity.

The gut microbiota is important for the maintenance of blood-cerebrospinal fluid barrier integrity.

Journal: The European journal of neuroscience

Published: September 05, 2022

Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia.

Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia.

Journal: International journal of molecular sciences

Published: August 05, 2022

Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function.

Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function.

Journal: iScience

Published: July 20, 2022

Showing 1-12 of 69

Last Updated: 09/26/2026